Alzheimer's Disease
The Alzheimer's Disease pipeline: 114 tracked drugs, 4 approved for this indication.
4 approved / phase 415 Phase 39 Phase 2/338 Phase 210 Phase 1/235 Phase 13 preclinical / unstaged
Compare the share prices of listed companies in Alzheimer's Disease →
Total attributable cost
$207.8B
$28,078/patient
Drug spend
Not yet sourced
All stages (2026 estimate) · US
The Alzheimer's Disease pipeline
Key trial results for every approved and late-stage drug: Alzheimer's Disease results by drug.